YK Bioventures Opportunities GP I, LLC - 13 Dec 2024 SCHEDULE 13G/A Report for CERO THERAPEUTICS HOLDINGS, INC. Common stock, par value $0.0001 per share (CERO)

Filing Manager: YK Bioventures Opportunities GP I, LLC
Reporting Manager: YK Bioventures Opportunities GP I, LLC
Security: CERO THERAPEUTICS HOLDINGS, INC. Common stock, par value $0.0001 per share
Symbol: CERO
Disclosed Ownership: 17,002 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 17 Dec 2024, 19:26:26 UTC
Date of event: 13 Dec 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
YK Bioventures Opportunities GP I, LLC	0%	17,002	17,002	/s/ Gary K. Yeung	By Gary K. Yeung, Managing Partner
YK Bioventures Opportunities Fund I, L.P.	0%	17,002	17,002	/s/ Gary K. Yeung	By YK Bioventures Opportunities GP I, LLC, its General Partner, By Gary K. Yeung, Managing Partner
Gary K. Yeung	0%	17,002	17,002	/s/ Gary K. Yeung	Gary K. Yeung
Mitchell W. Kossar	0%	17,002	17,002	/s/ Mitchell W. Kossar	Mitchell W. Kossar